Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04724252 · ClinicalTrials.gov registry record · Phase 2
Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children
A Phase 2 study of Pain, Postoperative, sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04724252: Recruiting Phase 2 study of Pain, Postoperative, sponsored by University of California, Davis.
NCT04724252 is a Phase 2 study of Pain, Postoperative that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 60 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04724252, a Phase 2 study of Pain, Postoperative, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin
Primary Outcome
Amount of pain medication needed after surgery
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Gabapentin
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
What NCT04724252 shows while recruiting
NCT04724252 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04724252 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04724252 about?
NCT04724252 is a clinical study titled "Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children". The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not ...
What is the current status of trial NCT04724252?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2021-08-23. Estimated completion is 2026-12-31.
What conditions does trial NCT04724252 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT04724252?
The interventions under investigation include: Placebo (OTHER), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT04724252?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04724252 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04724252's enrollment target sits among peer trials
60 79th of 113 higher than 30 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
RECRUITING · Phase 2
-
Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population
RECRUITING · Phase 2
-
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
ACTIVE NOT RECRUITING · Phase 2
-
Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management
COMPLETED · Phase 2
-
Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic
COMPLETED · Phase 2
-
Perioperative Pregabalin in Ureteroscopy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI